welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
New treatment reduces precancerous polyps in hereditary cancer patients
Inheriting a mutation in the APC gene leads to a nearly 100% lifetime risk of colorectal cancer. While colon cancer can be kept at bay by removing the large intestine, these patients also have up to a 15% risk of getting cancer in the small intestine, which is the leading cause of cancer death in this patient group. A new study published in the Journal of the American Medical Association (JAMA), has identified the first prevention treatment for these patients, a two-drug combination that significantly reduces the number and size of precancerous polyps in the small intestine.
expertly curated content related to this topic
- Colorectal Cancer GuidelinesThe American Society of Colon and Rectal...
- andrew goodwinPharmacologist...
- Non Steroidal Anti-Inflammatory Drugs (NSAID) and Aspirin for Preventing Colorectal Adenomas and CarcinomasBACKGROUND : There is evidence from expe...
- Cancer Prevention Pharmaceuticals (CPP) and Mallinckrodt Announce Results from Pivotal Phase 3 Trial of CPP-1X/Sulin...Cancer Prevention Pharmaceuticals, Inc.,...
- Familial Adenomatous Polyposis 1This description of FAP1 discusses clini...
- Levels of Rectal Mucosal Polyamines and Prostaglandin E2 Predict Ability of DFMO and Sulindac to Prevent Colorectal ...BACKGROUND & AIMS : Combination of p...
- Polyposis Syndromes of the Colon Current Management, Controversies and Future Directionhttp://www.slideserve.com/verena/polypos...
English
Portuguese
Spanish